Top Markets
#1 Derive Derive +33.13%
#2 Cross Cross +16.48%
#3 Geodnet Geodnet +10.63%
#4 Gama Token Gama Token +9.17%
#5 The Bitcoin Bull The Bitcoin Bull +8.05%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.25%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 Cap Cap +6.78%
#9 Humanity Humanity +6.62%
#10 Starpower Starpower +5.78%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA
Rank in Stocks #35931
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Share Price
$0.016
Last synced: 2024-03-11
Market Cap
$3.27M
Change (1 day)
-5.33%
Change (1 year)
0.00%
Country
US
Trade Invitae Corporation (NVTA)

Category

Healthcare
Revenue for Invitae Corporation (NVTA)
Revenue in Aug 2026 TTM: 0
According to Invitae Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Invitae Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US